Glutamate Reducing Interventions in Schizophrenia

Clinical trial NCT03321617 · COMPLETED

Trial details

NCT number: NCT03321617
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Clinical High Risk for Psychosis

Start date: 2018-04-17
Primary completion: 2020-03-13
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.